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Both Babesia and Borrelia burgdorferi are transmitted by
the Ixodide tick. It is not surprising then that cases of simulta¬
neous infection with these parasites have been reported and
that patients with Lyme disease sometimes have elevated
Babesia titers.5 It is interesting to speculate that our patient
may have acquired Babesia when she contracted Lyme dis¬
ease in 1985, and remained asymptomatic for several years.
The presence of a spleen has been believed to confer a mild,
or asymptomatic, clinical course in human babesiosis.3 Our
patient developed sudden respiratory failure despite radio-
logic evidence of a spleen. The clinical manifestations of babe¬
siosis in patients with a spleen may therefore be more severe
than previously recognized in patients. To our knowledge,
only one case of babesiosis associated with adult respiratory
distress syndrome has been reported in a patient with an
intact spleen.6 That patient died after sequential treatment
with quinine and chloroquine for 3 and 2 days, respec¬
tively.
Although data on the treatment ofbabesiosis are limited by
the rare occurrence of this disease, the treatment of choice
appears to include exchange transfusion7'8 and/or clindamycin
and oral quinine910 based on clinical observations and experi¬
mental data. In this case, the combination of exchange trans¬
fusion, clindamycin, and quinine completely eliminated Babe¬
sia from the blood within several days, without subsequent
relapse.
We believe that prompt treatment with this combination of
therapies was a major factor in our patient's survival and
would be beneficial in similar life-threatening Babesia
infections.
We thank the Centers for Disease Control, Atlanta, Ga, for supporting the
diagnosis of Babesia.
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Primary Hyperepinephrinemia in Patients
Without Pheochromocytoma
David H. P. Streeten, MB, DPhil, FRCP; Gunnar H. Anderson, Jr, MD; Mitchell Lebowitz, MD; PhilipJ. Speller, MD
\s=b\Clinical features of epinephrine release led to the finding of
spontaneously elevated plasma epinephrine concentrations in
five patients, in four of whom plasma norepinephrine concentra-
tions were normal. Adrenal medullary hyperplasia was sus-
pected in one patient, whose first cousin had multiple endocrine
neoplasia type lla,and in two others, all of whom have experi-
enced relief from symptoms during propranolol or atenolol ad-
ministration. The other two patients had unilateral adrenal cysts,
with negative metaiodobenzylguanidine scans and no histologi-
cal evidence of pheochromocytoma, but complete relief of symp-
toms by excision of the cysts. In one patient, Cushing's syn-
drome and associated hypertension, diabetes, and ischemic
finger-tip ulceration all disappeared after surgery. It is concluded
that spontaneous hyperepinephrinemic manifestations can be
relieved by \g=b\-blockersor, when an adrenal mass is present, by
unilateral adrenalectomy even when the metaiodobenzylguani-
dine test result is negative.
(Arch Intern Med. 1990;150:1528-1533)
Accepted for publication August 29,1989.
From the Department of Medicine, State University of New York Health
Science Center and Crouse Irving-Memorial Hospital, Syracuse.
Reprint requests to Department of Medicine, College of Medicine, SUNY
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lasma catecholamine concentrations are elevated and the
symptoms of hyperepinephrinemia are present in most
patients with pheochromocytoma and in many individuals as a
relatively nonspecific response to the "stress" of severe ill¬
ness.1·2 In most ofthese circumstances, plasma concentrations
of both norepinephrine and epinephrine are raised.1 Isolated
or predominant elevation of plasma epinephrine concentra¬
tion is a characteristic physiologic response to hypoglycemia,3
caffeine intake,4 cigarette smoking,5 and some emotional stim¬
uli1 and occurs in occasional patients with pheochromocyto¬
ma.6 There are theoretical reasons for postulating that exces¬
sive epinephrine release might play an important role in the
pathogenesis of essential hypertension,7,8 but there is no con¬
vincing evidence of hyperepinephrinemia in more than ex¬
tremely rare patients with hypertension. In the absence of
severe, stressful illnesses, hypoglycemia, and excessive use
of caffeine, tobacco, and perhaps other drugs, the combina¬
tion of clinical features and confirmatory evidence of elevated
plasma epinephrine concentrations on repeated occasions
strongly suggests the presence of a pheochromocytoma or of
adrenal medullary hyperplasia, as is seen in members of
families with multiple endocrine neoplasia type II.910 We
describe herein five patients in whom recurrent hyperepin¬
ephrinemia associated with symptoms that were improved or
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Fig 1 .—Left, Magnetic resonance image ofthe right adrenal mass (arrow) in patient 2. Right,
The opacity evident in the T2-weighted image indicates that the mass (arrow) is a cyst.
relieved by ß-blocking drugs was associated with a unilateral
adrenal cyst (two patients) or presumed adrenal medullary
hyperplasia (three patients), with excellent responses to uni¬
lateral adrenalectomy and ß-blocker therapy, respectively.
REPORT OF CASES
CASE 1.—A 45-year-old woman presented in 1981 with light-
headedness, tremors, and episodes of tachycardia that occurred al¬
most daily, most frequently 3 to 4 hours after lunch or during the
night, awakening her from sleep. During one of these nocturnal
episodes she went to the emergency room of a neighboring hospital
and was found to have sinus tachycardia (140 beats per minute).
During the attacks she often experienced pain in the right costoverte-
bral angle, and at the end of the episodes she frequently developed
carpal spasms, which were witnessed during her first admission to
our university hospital.
She had positive Chvostek and Trousseau signs and thyromegaly,
with normal levels of serum calcium (2.15 mmol/L), thyroxine
(107 nmol/L), and thyrotropin (3.2 mU/L). Serum electrolyte levels
were normal (sodium, 141 mmol/L; potassium, 3.5 mmol/L; chloride,
105 mmol/L; and bicarbonate, 28 mmol/L), except that the serum
potassium level fell during two spontaneous exacerbations of tachy¬
cardia and tremors to 3.2 and 2.9 mmol/L, associated with tetany. An
intravenous infusion of epinephrine at 2 µg/rmn reproduced the pa¬
tient's spontaneous symptoms, lowered the serum potassium level
from 3.8 to 2.9 mmol/L in 30 minutes, and induced a carpal spasm. All
symptoms were relieved within 3 minutes by propranolol hydrochlo¬
ride, 1 mg given intravenously.
An intravenous injection of histamine phosphate, 40 µg, increased
the blood pressure from 114/78 to 150/93 mm Hg and the heart rate
from 72 to 120 beats per minute. Plasma total catecholamine level
rose 2 minutes after the histamine injection, from 1.08 to 2.47 nmol/L
(measured on this occasion by radioenzymatic assay).
In response to an insulin tolerance test (using regular human
insulin, 0.15 U/kg) on three occasions between 1982 and 1985, plasma
epinephrine level11 rose to an extent indistinguishable from the re¬
sponse seen in nine normal subjects (data not shown). Computed
tomographic (CT) scans ofthe adrenal glands and pelvis were normal.
The observations made in 1981 suggested hyperepinephrinemia
resulting from adrenal medullary hyperplasia, and this speculation
was supported by the subsequent discovery and treatment of multi-
pie endocrine neoplasia type II in a first cousin in 1983, since there is
evidence that adrenal medullary hyperplasia frequently occurs in
some families with multiple endocrine neoplasia type II.910
The patient was given propranolol hydrochloride in a dose of 30 to
100 mg/d from 1981 until December 1986, when she was found to have
bronchial asthma. Propranolol therapy was discontinued, and after
having been totally asymptomatic for 5V2 years with propranolol
therapy, she continued to be free of symptoms without ß-blocker
therapy until March 1989, when she began to experience recurrence
of exhaustion and episodes of tachycardia and right lumbar pain.
These symptoms again responded well to a small dose of propranolol
hydrochloride (10 mg three times daily) without recurrence of her
respiratory symptoms. Computed tomographic scans of the adrenal
glands were normal in 1981,1982, 1983,1985, and 1989.
Case 2.—A 42-year-old woman developed tenderness in an en¬
larged thyroid gland in 1977 in association with euthyroidism. Remis¬
sion of her symptoms followed prednisone therapy for what was
considered to be granulomatous thyroiditis. She remained asymp¬
tomatic with suppressive doses of levothyroxine sodium
(0.1 mg/d) until 1983, when she began to complain of fatigue and
palpitations associated with spontaneous bouts of supraventricular
tachycardia and normal serum thyroxine (125 nmol/L) and thyrotro¬
pin (1.0 mU/L) concentrations.
The patient was given propranolol hydrochloride, 20 mg four times
daily. This appeared to produce some improvement but failed to
prevent the occurrence, with gradually increasing frequency be¬
tween 1983 and 1988, of bouts of severe palpitations, shakiness,
anxiety, nervousness, "weakness," excessive sweating, and pallor
associated with a feeling of warmth and backaches in the right costo-
vertebral angle. Phenoxybenzamine hydrochloride in a dose of 10 mg
orally was followed by severe facial flushing and fatigue and could not
be tolerated. There was no clinical evidence of Cushing's syndrome,
and the plasma cortisol concentration was normal and fell normally (to
40 nmol/L) at 8 AM after 1.0 mg of dexamethasone was given at
midnight. Serum thyroxine and thyrotropin levels continued to be
normal, but plasma epinephrine level was found to be intermittently
elevated to 538 pmol/L.
A CT scan in 1987 revealed a mass in the area ofthe right adrenal
gland, which appeared to be cystic, with peripheral calcification. A
magnetic resonance image confirmed the cystic nature of the lesion,
which measured 4.5x3.5x3.0 cm (Fig 1). Plasma catecholamine
levels showed normal or slightly elevated plasma epinephrine and
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consistently normal norepinephrine concentrations, but adrenal vein
catheterization revealed concentrations of epinephrine and norepi¬
nephrine of 906 and 76 nmol/L, respectively, in the right adrenal vein
blood, with concentrations no higher than those in the inferior vena
cava (0.87 and 2.45 nmol/L, respectively) in the left adrenal vein
blood. A right adrenal phlebogram showed a circumferential vein
encircling the cyst (Fig 2).
The frequency ofthe patient's bouts of feeling hot and sweaty, with
palpitations, tremulousness, abdominal cramps, and right costover-
tebral angle backaches, increased to three or four per month and were
frightening to the patient. It became evident that many of these
episodes occurred between 1 and 3 AM, awakening her from sleep.
The attacks were unimproved by chlorpromazine, 25 mg orally.
Although the result of a metaiodobenzylguanidine (MIBG) test12 was
negative, the evidence that the epinephrine was derived from the
adrenal cyst led to the decision to excise the cyst on Sept 27, 1988. It
weighed 14.5 g and contained a clear fluid with high concentrations of
epinephrine (83.9 nmol/L), norepinephrine (18.7 nmol/L), cortisol(2318 nmol/L), and aldosterone (20 nmol/L).
Fig 2.—Right adrenal phlebogram showing a circumferential vein(arrows) encircling the adrenal cyst in patient 2.
In the 13 months since the surgery, plasma epinephrine concentra¬
tions have been normal and the patient has been asymptomatic.
CASE 3.—A 56-year-old woman underwent subtotal gastrectomy
for recurrent peptic ulcération in 1975. A year later she was found to
have diabetes mellitus, type II, which was treated with diet and
isophane insulin, 24 U daily. Early in 1986 she developed painful, blue
discoloration of her fingertips with subsequent persistent ulcération
ofthe second and third fingertips ofthe left hand. In the fall of 1986
she was found to have anemia, and she began to notice deterioration of
diabetic control, with frequent spells of documented hypoglycemia, a
13.5-kg weight loss, progressive weakness, and episodes of palpita¬
tions, tremors, nervousness, a feeling of warmth with excessive
sweating, lightheadedness, pallor, and several ecchymoses.
On admission to the Crouse Irving-Memorial Hospital, Syracuse,
NY, the patient was found to have systolic hypertension with a wide
pulse pressure (blood pressure varying from 146/68 to 190/90 mm Hg)
without significant orthostatic change, but with tachycardia (100
beats per minute recumbent, 128 beats per minute standing). She was
emaciated (height, 162 cm; weight, 45 kg), with diminished muscle
mass, weakness, and thinned, sweaty skin with several ecchymoses
and ulcerated fingertips (second and third) on the left hand. There
was no evident excess of supraclavicular or cervicodorsal fat. No
peripheral edema and no cutaneous striae were present.
Laboratory studies disclosed anemia (hemoglobin level, 105 g/L),
neutrophil leukocytosis (11.1 x 109/L, with 0.81 segmented and 0.06
band cells), hypokalemia (serum potassium level, 2.7 mmol/L; sodium
level, 143 mmol/L; chloride level, 89 mmol/L; and bicarbonate level,
>40 mmol/L), negative results for cryoglobulin, and no evidence of
vasculitis on a skin biopsy specimen. There was clear-cut evidence of
hypercortisolism, daily urinary 17-hydroxycorticosteroid excretion
being 18.4 µ    /      of creatinine (normal, 0.6 to 2.0 µ    /mmol of
creatinine) before and 32.1 µ    /mmol of creatinine on the second day
of administration of dexamethasone (0.5 mg every 6 hours). There
was also elevation of plasma cortisol and catecholamine concentra¬
tions (Table 1). Urinary excretion ofcatecholamines was measured on
3 days and found to be as follows: norepinephrine, 39.8, 40.4, and
42.0 µ    /d (normal, 3.3 to 42 µ    /d); epinephrine, 64, 93, and
100 µ   /d (normal, 1.6 to 40 µ    /d); and dopamine, 238, 235, and
330 µ    /d (normal, 49 to 284 µ    /d). Thus, while the excretion of
norepinephrine and dopamine was close to the upper limits of the
respective reference ranges, epinephrine excretion was consistently
excessive.
A CT scan (Fig 3) demonstrated a right adrenal mass that mea¬
sured 2.4  1.5 cm. Adrenal vein catheterization was unsuccessful on
the right side but showed that the left adrenal gland was secreting
cortisol and epinephrine: plasma cortisol level in the left adrenal vein
was 6070 nmol/L, and in the inferior vena cava, 1076 nmol/L; plasma
epinephrine level in the left adrenal vein was 921 nmol/L, and in the
Table 1 .—Plasma Steroid and Catecholamine Results in Patient 3
Plasma Cortisol,
nmol/L
Therapy 8 am 4 PM
Plasma
Epinephrine,
pmol/L
Plasma
Norepinephrine
nmol/L
Plasma
Dopamine,
nmol/L
None
None
None
Dexamethasone, 0.5 mg every 6 h, 2nd d
After 2nd d
Dexamethasone, 2 mg every 6 h, 2nd d
18 d after adrenalectomy
3 mo after adrenalectomy
8 mo after adrenalectomy
16 mo after adrenalectomy
Normal (no treatment)
Recumbent
Standing
1214
2353
2985
2400
172
102
320
372
828
1504
1308
140-770
3832
2636
1845
82
311
217
110-490
110-490
4.09
2.65
4.89
1.48
2.68 (standing)
2.89 (standing)
2.18 (standing)
0.49-1.640
1.40-4.64
4.03
3.96
2.87
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inferior vena cava, 1.57 nmol/L. An MIBG scan did not confirm the
presence ofa pheochromocytoma, since no significant accumulation of
the radionuclide was seen in the adrenal glands.
On January 20,1987, a cystic right adrenal gland was removed and
found to show no histologie evidence of pheochromocytoma. The
patient's condition improved gradually but dramatically after the
surgery. She regained muscle mass, and her weight rose in the
subsequent 2 years to 48 kg. Blood pressure fell toward normal levels(152/80 mm Hg recumbent, 148/88 mm Hg standing) with normal
heart rates (76 beats per minute recumbent, 84 beats per minute
standing). The diabetes disappeared, and the plasma glucose level
has been consistently normal since surgery. The fingertip ulcération
healed, strength has returned to normal, and all symptoms have
disappeared during treatment with estrogen only (for the patient's
osteoporosis). Plasma cortisol and catecholamine concentrations
have been normal. The patient has returned to full-time work on a
factory assembly line without loss of time during the past 24 months.
CASE 4.—A 69-year-old woman presented with recent onset of
hypertension associated with severe pounding headaches that would
often awaken her at night. She complained also of palpitations, trem¬
ors, and lightheadedness, followed occasionally by syncope. Apart
from the hypertension with rather widely variable blood pressures(from 132/76 to 188/108 mm Hg) and some obesity, the physical
Fig 3.—Computed tomographic scan showing the mass (arrows) in
the left adrenal gland in patient 3, which was shown by ultrasound to be
cystic.
examination was unrevealing. Blood pressure was found, when nor¬
mal, to rise after administration ofhistamine phosphate (40 µg intra¬
venously) from 132/76 to 152/102 mm Hg and, when spontaneously
elevated, to fall from 240/106 to 124/72 mm Hg after administration of
phentolamine mesylate (5 mg intravenously). Plasma catecholamine
determination showed normal or mildly elevated levels of norepi¬
nephrine but almost invariably raised concentrations of epinephrine
(502 to 2554 pmol/L) in seven determinations. Since the CT scan failed
to confirm the strong suspicion that a pheochromocytoma was pre¬
sent, the patient was treated with propranolol hydrochloride, 20 mg
three times daily. Her blood pressure fell and she was asymptomatic
with this treatment.
Case 5.—A 42-year-old, obese woman had had brawny edema in
the legs since 1964, probably due to lymphatic obstruction (lymphe¬
dema precox). In 1983, she began to complain ofnight sweats (usually
between 2 and 3 AM), associated with heat intolerance, tremors,
lightheadedness, and headaches. She was found to have diabetes
mellitus, type II, which responded well to a low-carbohydrate,
low-energy diet, without improving her symptoms. Apart from the
brawny edema and generalized obesity (height, 152 cm; weight,
106.5 kg), the results of physical examination were unrevealing.
Plasma epinephrine levels were found to be very high (Table 2), but a
CT scan ofthe abdomen and an MIBG test were negative. Symptoms
were strikingly reduced by treatment with atenolol, 50 mg/d, for 6
months.
RESULTS
All ofthe patients were seen because of symptoms sugges¬
tive of hyperepinephrinemia: palpitations, nervousness,
"weakness," excessive sweating, pounding headaches, trem¬
ors, and feeling hot but with cutaneous pallor. All patients
were found on more than one occasion to have elevated plasma
epinephrine concentrations, between 491 and 2636 pmol/L,
measured by an electrometric method after separation by
high-performance liquid chromatography.11 Computed tomo¬
graphic scans revealed enlargement of one adrenal gland in
two of the patients and normal adrenal glands in the other
three patients. The MIBG scans ofthe adrenal glands12 were
negative in the four patients who were studied with this
procedure.
Clinical and Laboratory Findings
Most of the symptoms in the five patients were consistent
with the persistent or episodic presence ofhyperepinephrine¬
mia (Table 3). However, the predominant or presenting fea¬
tures were quite variable. Plasma epinephrine concentration
was elevated above 491 pmol/L in all five patients, while
plasma norepinephrine level was normal except in patient 3
Table 2.—Laboratory Studies*
Patient
Plasma
Norepinephrine,
nmol/l
Plasma
Epinephrine,
pmol/L
Lying Standing Lying Standing
Urinary
VMA,
µ    /d
CTof
Adrenals
MIBG
Test
Evidence of
Other Disorders
2
3
4
5
Normal
ranges
0.469
0.655
2.653
1.15
1.20
0.490-1.637
2.042
2.271
4.612
3.766
1.676
1.365-4.64
932
186-535
2636
2347
2118
110-490
5104
235
2374
2554
650
110-490
45.4
59.5
15-45
Normal
Adrenal mass
Adrenal mass
Normal
Normal
Normal
Negative
Negative
Negative
Negative
Negative
MEN type IIA
in 1 st cousin
Diabetes mellitus
Cushing's syndrome(severe)
Hypertension
Diabetes mellitus
Negative
*VMA indicates vanillylmandelic acid; CT, computed tomography; MIBG, metaiodobenzylguanidine; and MEN, multiple endocrine neoplasia.
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Table 3.—Clinical Features
Recumbent
Patient/ Palpita-
Age, y tions
Nervous¬
ness "Weakness"
Excess
Sweating
Head¬
aches
Light¬
headedness Tremors
Feeling
Hot Pallor
Blood
Pressure,
mm Hg
Pulse,
Beats/min
Orthostatic
Hypotension
1/45
2/42
3/56
4/69
5/42
100/64
134/98
146/78
132/74
166/82
68
96
100
92
76
LU
m
CL
4200
3600
3000
2400
1800
1200
600
300
10
< Normal Subjects
 Patients With Hyperepinephrinemia
' Patients With Hyperepinephrinemia
After Surgery
20 30 40 50 60 70
Age, y
Fig 4. —Plasma epinephrine concentrations in the five patients com¬
pared with those of normal subjects of various ages. The open circles
show plasma epinephrine concentrations in the two patients with
adrenal cysts after surgical excision of the cysts. The horizontal line
delineates the upper limit of the normal range of plasma epinephrine
concentrations.
(Table 2). The plasma epinephrine concentrations in the five
patients are compared with those in 33 healthy volunteers in
Fig 4.
Histologie Examination ofthe Adrenal Cysts
There was a thick, fibrous tissue lining ofthe cysts removed
from patients 2 and 3, in which smooth muscle cells were
present. Adrenal cortical and medullary cells were present in
both cyst walls, with cortical hyperplasia in patient 3. The
medullary cells were active, with prominent nuclei, and
showed the usual staining with neuron-specific enolase. No
evidence of pheochromocytoma was found in the adrenal tis¬
sue removed from either patient.
COMMENT
The patients described in this report all had intermittent,
frequently nocturnal, or continuous elevation of plasma epi¬
nephrine concentration, with the symptoms expected from
these findings and relief of the symptoms by unilateral adre¬
nalectomy in the two patients with unilateral adrenal cysts or
therapy with ß-adrenergic blocking drugs. Although the re¬
lief of symptoms by ß-adrenergic blockade is not conclusive
evidence of excessive epinephrine release, it is certainly con¬
sistent with this possibility. Elevations ofplasma epinephrine
concentration of the magnitude seen in these patients can
occur during severe emotional or physical stresses, during
hypoglycemia, or in the presence of a pheochromocytoma;
none of these conditions was found to be present. '
Although the evidence relating to the stimulation of epi¬
nephrine release in these patients is fragmentary, one patient(patient 1) showed a normal epinephrine response to insulin-
induced hypoglycemia. One of the two patients with adrenal
cysts and all three patients who were thought to have adrenal
medullary hyperplasia experienced spontaneous episodes
suggesting acute hyperepinephrinemia, which were stimu¬
lated by epinephrine infusion in one of them. In all of the
patients these episodes awakened the individuals frequently
in the early hours of the morning and were, therefore, pre¬
sumably not induced by any type of"stress. " Whether adrenal
medullary secretion plays a physiologic role in maintaining
euglycemia in the absence of food intake during sleep, and
might have been excessive in these patients, is not known.
There is evidence that epinephrine release plays an important
role in the restoration of euglycemia after insulin-induced
hypoglycemia in diabetic patients, but this role ofepinephrine
is crucial only in glucagon deficiency.1314 Since hyperepineph¬
rinemia was frequently shown to be present in the immediate
postprandial state in these patients, however, it is clear that
hypoglycemia is not the only trigger to excessive epinephrine
release in these patients.
The diagnosis of hyperepinephrinemia was suspected on
clinical grounds since the symptoms of hyperepinephrinemia
were present in the absence of evident hypoglycémie or other
stresses or pheochromocytoma. Measurements ofplasma epi¬
nephrine concentration or urinary epinephrine excretion es¬
tablished the diagnosis. Pheochromocytomas associated with
excessive epinephrine release can usually, but not always, be
excluded by a normal CT scan ofthe abdomen and pelvis. The
presence of an adrenal mass in two patients made it necessary
to perform MIBG scans. Although the MIBG test is not very
sensitive and may be negative in patients with small pheo¬
chromocytomas, it is usually positive in lesions as large as
those found by CT scan in patients 2 and 3. When the sono¬
gram suggested an adrenal cyst in two patients and MIBG
scans did not show excessive concentrations of the radionu¬
clide within the cysts, we were hesitant to proceed with
surgery. However, the strong evidence of severe hypercorti¬
solism in patient 3 that was unsuppressible even with dexa¬
methasone in a dose of 2 mg given every 6 hours led us to
recommend surgery in this patient. In retrospect, this was a
fortunate decision, since the patient, who had been extremely
ill and considered preterminal by several of her physicians,
was restored by adrenalectomy to an active, productive,
asymptomatic life. The decision to remove the adrenal cyst in
patient 2 was more difficult and was resisted for many months
until it became evident that her attacks of hyperepinephrine¬
mia were becoming more frequent and more severe despite
the administration ofpropranolol in the maximal dose that she
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could tolerate while continuing to work. The finding of ex¬
tremely high levels ofplasma epinephrine in the vein draining
the cyst and not in the contralateral adrenal vein indicated
that the epinephrine excess was probably coming from the
adrenal cyst.
Histologie examination in our pathology department and in
a national consulting laboratory gave no evidence of a pheo¬
chromocytoma in either adrenal cyst. Whether the medullary
cells in the wall of the cyst were remnants of a previous
pheochromocytoma that had undergone necrosis could not be
decided. While the mass of the adrenal medullary cells was
insufficient to provide a positive MIBG test, it was clearly
sufficient in both patients to cause severe and, in one instance,
incapacitating ill health.
It was of interest to observe the occurrence of severe
hypokalemia in two ofour five patients. Epinephrine adminis¬
tration is known to induce hypokalemia rapidly by enhancing
cellular uptake of potassium through a ß2-receptor-mediated
effect.15"17 This is probably the mechanism of hypokalemia
after myocardial infarction.18 The occurrence of hypokalemia
in our patients and its usual absence in patients with pheo¬
chromocytoma19 might result from the more episodic release
of epinephrine in the patients described herein or from the
usual absence of concomitant, excessive norepinephrine re¬
lease, which is characteristic of most patients with
pheochromocytoma.
This study was supported by research grant ROI AG03055 from the National
Heart, Lung, and Blood Institute, Bethesda, Md, and Clinical Research Center
grant RR229 from the Division of Research Facilities and Resources, US Public
Health Service.
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